Pharma & Biotech

IO Biotech witnessed a dramatic single-day surge of more than 25% in its share price yesterday. This powerful rally was...

The telehealth provider Hims & Hers finds itself navigating turbulent market conditions. Despite management's confident move to authorize a substantial...

The Danish pharmaceutical giant Novo Nordisk is confronting significant pressure across multiple areas of its business. A failed multi-billion dollar...

The prolonged regulatory battle has reached a critical resolution point, with Illumina commencing its mandated divestiture from GRAIL. This strategic...

Investors are driving substantial gains for Outlook Therapeutics as the company achieves a critical regulatory breakthrough. The catalyst behind this...

A surprising development emerged in mid-November when pharmaceutical giant Pfizer divested 54.7% of its stake in BioNTech, triggering a significant...

The publicly traded journey of G1 Therapeutics has reached its conclusion. The biotechnology firm ceased trading on the NASDAQ effective...

The future of CureVac as an independent entity now rests in shareholders' hands as a decisive vote approaches. Investors will...

Intellia Therapeutics, a prominent player in the gene-editing sector, is confronting a severe crisis after a fatality occurred in a...

A significant vote of confidence has been placed in Redcare Pharmacy, not through words, but through a substantial financial commitment....